Advertisement
Screener

PROPANC BIOPHARMA, INC. (PPCB) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

PROPANC BIOPHARMA, INC. Operating Cash Flow

PROPANC BIOPHARMA, INC. (PPCB) reported Operating Cash Flow of -$4.08 million for the 9-month period ending 2026-03-31, per its S-1 filed 2026-07-17.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-17

  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.14M.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$999.14K, a 5434.72% decline year-over-year.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.94M.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$92.19K.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$1.11M.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$1.44M.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$1.15M.
  • PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$1.85M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 51 monthNet Cash Provided by (Used in) Operating Activities 54 monthNet Cash Provided by (Used in) Operating Activities 57 monthNet Cash Provided by (Used in) Operating Activities 60 monthNet Cash Provided by (Used in) Operating Activities 63 monthNet Cash Provided by (Used in) Operating Activities 66 monthNet Cash Provided by (Used in) Operating Activities 68 monthNet Cash Provided by (Used in) Operating Activities 72 monthNet Cash Provided by (Used in) Operating Activities 75 monthNet Cash Provided by (Used in) Operating Activities 77 month
2026-03-31-$1.14M
derived: S-1 9 month − S-1 6 month · filed 2026-07-17
-$2.14M
derived: sum of 2 quarters · filed 2026-07-17
-$4.08M
S-1 · filed 2026-07-17
-$4.17M
derived: sum of 4 quarters · filed 2026-07-17
2025-12-31-$999.14K
derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10
-$2.94M
S-1 · filed 2026-04-10
-$3.03M
derived: sum of 3 quarters · filed 2026-07-17
-$3.13M
derived: sum of 4 quarters · filed 2026-07-17
2025-09-30-$1.94M
10-Q · filed 2025-11-14
-$2.03M
derived: sum of 2 quarters · filed 2026-07-17
-$2.13M
derived: sum of 3 quarters · filed 2026-07-17
-$2.11M
derived: sum of 4 quarters · filed 2026-07-17
2025-06-30-$92.19K
derived: S-1 12 month − S-1 9 month · filed 2026-07-17
-$188.38K
derived: sum of 2 quarters · filed 2026-07-17
-$169.65K
derived: sum of 3 quarters · filed 2026-07-17
-$405.17K
S-1 · filed 2026-07-17
2025-03-31-$96.20K
derived: S-1 9 month − S-1 6 month · filed 2026-07-17
-$77.47K
derived: sum of 2 quarters · filed 2026-07-17
-$312.98K
S-1 · filed 2026-07-17
-$377.98K
10-Q · filed 2025-05-15
-$572.95K
derived: sum of 4 quarters · filed 2026-07-17
2024-12-31$18.73K
derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10
-$216.79K
S-1 · filed 2026-04-10
-$241.79K
10-Q · filed 2025-02-14
-$476.75K
derived: sum of 3 quarters · filed 2026-07-17
-$579.56K
derived: sum of 4 quarters · filed 2026-07-17
2024-09-30-$235.51K
10-Q · filed 2025-11-14
-$495.48K
derived: sum of 2 quarters · filed 2026-07-17
-$598.29K
derived: sum of 3 quarters · filed 2026-07-17
-$837.18K
derived: sum of 4 quarters · filed 2026-07-17
2024-06-30-$259.97K
derived: S-1 12 month − 10-Q 9 month · filed 2026-07-17
-$362.78K
derived: sum of 2 quarters · filed 2026-07-17
-$601.66K
derived: sum of 3 quarters · filed 2026-07-17
-$935.12K
S-1 · filed 2026-07-17
2024-03-31-$102.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15
-$341.69K
derived: sum of 2 quarters · filed 2025-05-15
-$675.15K
10-Q · filed 2025-05-15
-$853.13K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$238.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14
-$572.34K
10-Q · filed 2025-02-14
-$750.32K
derived: sum of 3 quarters · filed 2025-02-14
-$943.05K
derived: sum of 4 quarters · filed 2025-02-14
2023-09-30-$333.46K
10-Q · filed 2024-11-14
-$511.43K
derived: sum of 2 quarters · filed 2024-11-14
-$704.17K
derived: sum of 3 quarters · filed 2024-11-14
-$929.39K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$177.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
-$370.71K
derived: sum of 2 quarters · filed 2024-09-30
-$595.94K
derived: sum of 3 quarters · filed 2024-09-30
-$1.11M
10-K · filed 2024-09-30
2023-03-31-$192.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
-$417.96K
derived: sum of 2 quarters · filed 2024-05-15
-$927.28K
10-Q · filed 2024-05-15
-$1.34M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$225.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-20
-$734.54K
10-Q · filed 2024-02-20
-$1.15M
derived: sum of 3 quarters · filed 2024-02-20
-$1.46M
derived: sum of 4 quarters · filed 2024-02-20
2022-09-30-$509.31K
10-Q · filed 2023-11-14
-$920.31K
derived: sum of 2 quarters · filed 2023-11-14
-$1.23M
derived: sum of 3 quarters · filed 2023-11-14
-$1.46M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$411.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
-$725.21K
derived: sum of 2 quarters · filed 2023-09-28
-$949.55K
derived: sum of 3 quarters · filed 2023-09-28
-$1.44M
10-K · filed 2023-09-28
2022-03-31-$314.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15
-$538.55K
derived: sum of 2 quarters · filed 2023-05-15
-$1.03M
10-Q · filed 2023-05-15
-$1.26M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$224.34K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10
-$711.09K
10-Q · filed 2023-02-10
-$947.38K
derived: sum of 3 quarters · filed 2023-02-10
-$1.42M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30-$486.76K
10-Q · filed 2022-11-14
-$723.04K
derived: sum of 2 quarters · filed 2022-11-14
-$1.19M
derived: sum of 3 quarters · filed 2022-11-14
-$1.45M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$236.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28
-$704.29K
derived: sum of 2 quarters · filed 2022-09-28
-$965.32K
derived: sum of 3 quarters · filed 2022-09-28
-$1.15M
10-K · filed 2022-09-28
2021-03-31-$468.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16
-$729.03K
derived: sum of 2 quarters · filed 2022-05-16
-$908.98K
10-Q · filed 2022-05-16
-$1.41M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$261.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14
-$440.98K
10-Q · filed 2022-02-14
-$940.63K
derived: sum of 3 quarters · filed 2022-02-14
-$1.15M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30-$179.95K
10-Q · filed 2021-11-12
-$679.61K
derived: sum of 2 quarters · filed 2021-11-12
-$886.66K
derived: sum of 3 quarters · filed 2021-11-12
-$1.30M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$499.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28
-$706.71K
derived: sum of 2 quarters · filed 2021-09-28
-$1.12M
derived: sum of 3 quarters · filed 2021-09-28
-$1.85M
10-K · filed 2021-09-28
2020-03-31-$207.05K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
-$623.60K
derived: sum of 2 quarters · filed 2021-05-14
-$1.35M
10-Q · filed 2021-05-14
-$1.62M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$416.55K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12
-$1.14M
10-Q · filed 2021-02-12
-$1.41M
derived: sum of 3 quarters · filed 2021-02-12
-$2.15M
derived: sum of 4 quarters · filed 2021-02-12
2019-09-30-$726.33K
10-Q · filed 2020-11-16
-$992.56K
derived: sum of 2 quarters · filed 2020-11-16
-$1.73M
derived: sum of 3 quarters · filed 2020-11-16
-$2.37M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$266.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01
-$1.00M
derived: sum of 2 quarters · filed 2020-10-01
-$1.64M
derived: sum of 3 quarters · filed 2020-10-01
-$2.06M
10-K · filed 2020-10-01
2019-03-31-$737.02K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15
-$1.37M
derived: sum of 2 quarters · filed 2020-05-15
-$1.79M
10-Q · filed 2020-05-15
-$2.24M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$637.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14
-$1.06M
10-Q · filed 2020-02-14
-$1.50M
derived: sum of 3 quarters · filed 2020-02-14
-$2.16M
derived: sum of 4 quarters · filed 2020-02-14
2018-09-30-$419.20K
10-Q · filed 2019-11-14
-$866.76K
derived: sum of 2 quarters · filed 2019-11-14
-$1.53M
derived: sum of 3 quarters · filed 2019-11-14
-$1.81M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$447.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-15
-$1.11M
derived: sum of 2 quarters · filed 2019-10-15
-$1.39M
derived: sum of 3 quarters · filed 2019-10-15
-$2.18M
10-K · filed 2019-10-15
2018-03-31-$658.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15
-$944.42K
derived: sum of 2 quarters · filed 2019-05-15
-$1.73M
10-Q · filed 2019-05-15
2017-12-31-$285.66K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14
-$1.07M
10-Q · filed 2019-02-14
2017-09-30-$785.67K
10-Q · filed 2018-11-13
2017-06-30-$2.05M
10-K · filed 2018-09-17
2014-12-31$172.19K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17
$272.00K
10-Q · filed 2015-02-17
$636.11K
derived: sum of 3 quarters · filed 2015-02-17
$600.26K
derived: sum of 4 quarters · filed 2015-02-17
2014-09-30$99.81K
10-Q · filed 2014-11-19
$463.92K
derived: sum of 2 quarters · filed 2014-11-19
$428.07K
derived: sum of 3 quarters · filed 2014-11-19
$401.44K
derived: sum of 4 quarters · filed 2014-11-19
2014-06-30$364.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-10-14
$328.26K
derived: sum of 2 quarters · filed 2014-10-14
$301.63K
derived: sum of 3 quarters · filed 2014-10-14
$226.44K
10-K · filed 2014-10-14
2014-03-31-$35.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20
-$62.48K
derived: sum of 2 quarters · filed 2014-05-20
-$137.67K
10-Q · filed 2014-05-20
-$169.61K
derived: sum of 4 quarters · filed 2014-05-20
-$2.79M
10-Q · filed 2014-05-20
2013-12-31-$26.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14
-$101.82K
10-Q · filed 2014-02-14
-$133.77K
derived: sum of 3 quarters · filed 2014-02-14
-$152.57K
derived: sum of 4 quarters · filed 2014-05-20
-$2.75M
10-Q · filed 2014-02-14
2013-09-30-$75.18K
10-Q · filed 2013-11-14
-$107.13K
derived: sum of 2 quarters · filed 2013-11-14
-$125.93K
derived: sum of 3 quarters · filed 2014-05-20
-$131.84K
derived: sum of 4 quarters · filed 2014-05-20
-$2.73M
10-Q · filed 2013-11-14
2013-06-30-$31.95K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15
-$50.75K
derived: sum of 2 quarters · filed 2014-05-20
-$56.65K
derived: sum of 3 quarters · filed 2014-05-20
-$128.65K
10-K · filed 2013-10-15
-$2.65M
10-K · filed 2013-10-15
2013-03-31-$18.80K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20
-$24.71K
derived: sum of 2 quarters · filed 2014-05-20
-$96.70K
10-Q · filed 2014-05-20
-$152.66K
derived: sum of 4 quarters · filed 2014-05-20
-$2.62M
10-Q · filed 2013-05-20
2012-12-31-$5.90K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14
-$77.90K
10-Q · filed 2014-02-14
-$133.85K
derived: sum of 3 quarters · filed 2014-02-14
-$208.02K
derived: sum of 4 quarters · filed 2014-02-14
-$2.60M
10-Q · filed 2013-02-20
2012-09-30-$72.00K
10-Q · filed 2013-11-14
-$127.95K
derived: sum of 2 quarters · filed 2013-11-14
-$202.12K
derived: sum of 3 quarters · filed 2013-11-14
-$203.32K
derived: sum of 4 quarters · filed 2013-11-14
-$2.59M
10-Q · filed 2012-11-19
2012-06-30-$55.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15
-$130.12K
derived: sum of 2 quarters · filed 2013-10-15
-$131.32K
derived: sum of 3 quarters · filed 2013-10-15
-$170.28K
10-K · filed 2013-10-15
-$2.52M
10-K · filed 2012-10-15
2012-03-31-$74.16K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20
-$75.37K
derived: sum of 2 quarters · filed 2013-05-20
-$114.32K
10-Q · filed 2013-05-20
-$194.94K
derived: sum of 4 quarters · filed 2013-05-20
-$2.47M
10-Q · filed 2012-05-21
2011-12-31-$1.20K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-20
-$40.16K
10-Q · filed 2013-02-20
-$120.78K
derived: sum of 3 quarters · filed 2013-02-20
-$213.90K
derived: sum of 4 quarters · filed 2013-02-20
-$2.39M
10-Q/A · filed 2012-03-07
2011-09-30-$38.95K
10-Q · filed 2012-11-19
-$119.57K
derived: sum of 2 quarters · filed 2012-11-19
-$212.69K
derived: sum of 3 quarters · filed 2012-11-19
2011-06-30-$80.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15
-$173.74K
derived: sum of 2 quarters · filed 2012-10-15
-$1.40M
10-K · filed 2012-10-15
2011-03-31-$93.12K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-05-21
-$1.31M
10-Q · filed 2012-05-21
2010-12-31-$1.22M
10-Q/A · filed 2012-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
NANOVIRICIDES, INC. (NNVC)United States$0.031B
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45